Chief Executive Officer of Synlogic Inc.
Dr. Gutiérrez-Ramos has over 20 years of drug discovery and development experience from leading global biopharmaceutical companies. He currently serves as Chief Executive Officer of Synlogic Inc. Prior to joining Synlogic, Dr. Gutierrez-Ramos was Group Senior Vice President of Worldwide Research and Development and Global Head of Biotherapeutics Research and Development at Pfizer Inc., a pharmaceutical company, from November 2009 to May 2015. Dr. Gutierrez-Ramos received a B.S. in chemistry from Universidad Complutense de Madrid and his Ph.D. in Immunology from the Universidad Autonoma de Madrid. Dr. Gutiérrez-Ramos currently serves as a board member for Momenta Pharmaceuticals and Massachusetts Biotechnology Council, and is a member of the scientific advisory boards of Massachusetts Life Sciences Center, Bicycle Therapeutics and Bluefin Biomedicines.